Stock listing
OTC:ATXI Avenue Therapeutics, Inc. Stock
Home listing (OTC) of Avenue Therapeutics, Inc.
Follow Avenue Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · OTC:ATXI
$0.28 USD 0.00 (0.0%)
Close on Nov 16, 2026
- Day range
- $0.28 – $0.28 USDNov 16, 2026
- Volume
- 7 sharesNov 16, 2026
- Market cap
- $922,591 USDAt the close on Nov 16, 2026 · price × 3.29M shares outstanding
- 52-week range
- $0.15 – $0.957 USDLowest and highest trades, Nov 17, 2025 – Nov 16, 2026
- Traded on an average day
- $2,931 USDMedian day 329 shares · 21 days with no trades · last 3 months, Aug 17, 2026 – Nov 16, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| OTC:ATXI · Home | $0.28 USD | 0.00 (0.0%) | 7 | $0.28 | $0.28 | $0.28 | $0.28 | Close on Nov 16, 2026 |
Daily closes
Last 3 months, Aug 17, 2026 – Nov 16, 2026 · OTC:ATXI · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.28 | 0.00 | 0.0% | $0.28 | $0.28 | $0.28 | 7 | |
| $0.28 | 0.00 | 0.0% | $0.28 | $0.28 | $0.28 | 0 | |
| $0.28 | -0.025 | -8.3% | $0.28 | $0.28 | $0.28 | 2,828 | |
| $0.305 | 0.00 | 0.0% | $0.305 | $0.305 | $0.305 | 0 | |
| $0.305 | 0.00 | 0.0% | $0.305 | $0.305 | $0.305 | 0 | |
| $0.305 | -0.124 | -28.8% | $0.28 | $0.429 | $0.28 | 1,129 | |
| $0.429 | 0.00 | 0.0% | $0.429 | $0.429 | $0.429 | 0 | |
| $0.429 | +0.027 | +6.7% | $0.429 | $0.429 | $0.429 | 117 | |
| $0.402 | 0.00 | 0.0% | $0.402 | $0.402 | $0.402 | 0 | |
| $0.402 | 0.00 | 0.0% | $0.402 | $0.402 | $0.402 | 0 | |
| $0.402 | -0.026 | -6.1% | $0.402 | $0.402 | $0.402 | 2,097 | |
| $0.428 | +0.048 | +12.6% | $0.428 | $0.428 | $0.428 | 301 | |
| $0.38 | 0.00 | 0.0% | $0.38 | $0.38 | $0.38 | 0 | |
| $0.38 | -0.019 | -4.6% | $0.38 | $0.38 | $0.38 | 5,007 | |
| $0.399 | -0.014 | -3.3% | $0.417 | $0.417 | $0.399 | 2,115 | |
| $0.412 | +0.027 | +7.1% | $0.402 | $0.412 | $0.40 | 10,999 | |
| $0.385 | -0.019 | -4.8% | $0.385 | $0.385 | $0.385 | 234 | |
| $0.404 | 0.00 | 0.0% | $0.404 | $0.404 | $0.404 | 0 | |
| $0.404 | 0.00 | 0.0% | $0.404 | $0.404 | $0.404 | 0 | |
| $0.404 | -0.026 | -6.0% | $0.404 | $0.404 | $0.404 | 104 | |
| $0.43 | 0.00 | 0.0% | $0.43 | $0.43 | $0.43 | 0 | |
| $0.43 | 0.00 | 0.0% | $0.43 | $0.43 | $0.43 | 0 | |
| $0.43 | 0.00 | 0.0% | $0.43 | $0.43 | $0.43 | 0 | |
| $0.43 | +0.01 | +2.4% | $0.43 | $0.43 | $0.43 | 329 | |
| $0.42 | +0.019 | +4.9% | $0.44 | $0.44 | $0.42 | 3,036 | |
| $0.401 | -0.029 | -6.8% | $0.449 | $0.449 | $0.401 | 488 | |
| $0.43 | 0.00 | 0.0% | $0.43 | $0.43 | $0.43 | 0 | |
| $0.43 | -0.019 | -4.3% | $0.43 | $0.43 | $0.43 | 249 | |
| $0.449 | +0.069 | +18.2% | $0.382 | $0.449 | $0.382 | 6,121 | |
| $0.38 | 0.00 | 0.0% | $0.38 | $0.38 | $0.38 | 0 | |
| $0.38 | -0.028 | -6.8% | $0.38 | $0.38 | $0.38 | 604 | |
| $0.408 | +0.048 | +13.2% | $0.408 | $0.408 | $0.408 | 1,082 | |
| $0.36 | -0.04 | -10.0% | $0.40 | $0.492 | $0.36 | 19,791 | |
| $0.40 | 0.00 | 0.0% | $0.27 | $0.40 | $0.27 | 10,241 | |
| $0.40 | -0.10 | -20.0% | $0.465 | $0.465 | $0.40 | 15,165 | |
| $0.50 | 0.00 | 0.0% | $0.50 | $0.50 | $0.50 | 0 | |
| $0.50 | 0.00 | 0.0% | $0.50 | $0.50 | $0.50 | 0 | |
| $0.50 | +0.14 | +38.9% | $0.40 | $0.68 | $0.40 | 9,236 | |
| $0.36 | -0.14 | -28.0% | $0.26 | $0.36 | $0.26 | 395 | |
| $0.50 | +0.022 | +4.7% | $0.46 | $0.538 | $0.25 | 4,912 | |
| $0.478 | 0.00 | 0.0% | $0.478 | $0.478 | $0.478 | 0 | |
| $0.478 | 0.00 | 0.0% | $0.478 | $0.478 | $0.478 | 0 | |
| $0.478 | -0.086 | -15.3% | $0.546 | $0.546 | $0.45 | 10,715 | |
| $0.564 | -0.071 | -11.2% | $0.66 | $0.66 | $0.564 | 3,515 | |
| $0.635 | -0.047 | -6.8% | $0.642 | $0.72 | $0.625 | 40,983 | |
| $0.682 | +0.082 | +13.6% | $0.60 | $0.682 | $0.54 | 21,465 | |
| $0.60 | -0.224 | -27.2% | $0.80 | $0.90 | $0.60 | 30,817 | |
| $0.824 | +0.172 | +26.4% | $0.652 | $0.846 | $0.652 | 37,513 | |
| $0.652 | +0.112 | +20.7% | $0.57 | $0.652 | $0.564 | 7,408 | |
| $0.54 | -0.004 | -0.8% | $0.55 | $0.55 | $0.502 | 5,756 | |
| $0.545 | -0.025 | -4.5% | $0.52 | $0.57 | $0.488 | 4,000 | |
| $0.57 | 0.00 | 0.0% | $0.57 | $0.57 | $0.57 | 0 | |
| $0.57 | +0.05 | +9.6% | $0.52 | $0.57 | $0.445 | 10,256 | |
| $0.52 | +0.068 | +15.0% | $0.577 | $0.577 | $0.519 | 3,020 | |
| $0.452 | 0.00 | 0.0% | $0.452 | $0.452 | $0.452 | 308 | |
| $0.452 | -0.125 | -21.7% | $0.49 | $0.49 | $0.452 | 5,140 | |
| $0.577 | +0.127 | +28.2% | $0.47 | $0.577 | $0.432 | 23,056 | |
| $0.45 | +0.04 | +9.8% | $0.40 | $0.45 | $0.40 | 30,095 | |
| $0.41 | +0.152 | +59.2% | $0.40 | $0.419 | $0.40 | 17,816 | |
| $0.258 | 0.00 | 0.0% | $0.258 | $0.258 | $0.258 | 0 | |
| $0.258 | 0.00 | 0.0% | $0.258 | $0.258 | $0.258 | 1 | |
| $0.258 | 0.00 | 0.0% | $0.258 | $0.258 | $0.258 | 0 | |
| $0.258 | 0.00 | 0.0% | $0.258 | $0.258 | $0.258 | 3 | |
| $0.258 | 0.00 | 0.0% | $0.258 | $0.258 | $0.258 | 36 | |
| $0.258 | 0.00 | 0.0% | $0.258 | $0.258 | $0.258 | 93 |
Splits
2 splits since 2022 · OTC:ATXI · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-75 | Consolidation | |
| 1-for-15 | Consolidation |
- Ticker
- OTC:ATXI
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Feb 23, 2026
Avenue Therapeutics Enters into Exclusive Worldwide License Agreement for ATX-04 for the Treatment of Pompe Disease
Latest news
Avenue Therapeutics Enters into Exclusive Worldwide License Agreement for ATX-04 for the Treatment of Pompe Disease
Feb 23, 2026
Closed $0.28 (+86.7%) on Feb 23, 2026
Avenue Therapeutics, Inc. on 6ix
- News releases
- 1 in the last 12 months · 2 in all · newest Feb 23, 2026 · oldest 2025
- Decks
- 17 decks · latest Oct 4, 2023
Where Avenue Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| OTC:ATXI · Home listing · This page | OTC | United States | USD |
| Lang & Schwarz:A40BWJ | Lang & Schwarz | Germany | EUR |
| LS Exchange:A40BWJ | LS Exchange | Germany | EUR |
Valuation
Statements: 4 quarters to Sep 30, 2026 · price Nov 16, 2026
- Enterprise value
- −$597,409 USD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- Negative equity
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- Negative equity
- Beta vs S&P 500
- -1.55
Team and board
Officers
| Officer | Role |
|---|---|
| Alexandra MacLean | Chief Executive Officer, Director |
| David Jin | Interim Chief Financial Officer and Chief Operating Officer |
Board
| Director | Role |
|---|---|
| Jay Kranzler | Chairman of the Board of Directors |
| Alexandra MacLean | Chief Executive Officer, Director |
| Curtis Oltmans | Director |
| Faith Charles | Director |
| Lindsay A. Rosenwald | Director |
| Neil Herskowitz | Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2025 | Nov 13, 2025 | +1.2% |
| Q2 2025 | Aug 14, 2025 | +14.0% |
| Q1 2025 | May 13, 2025 · Before open | −25.4% |
| Q4 2024 | Mar 31, 2025 | −6.8% |
| Q3 2024 | Nov 14, 2024 · After close | +2.7% |
| Q2 2024 | Aug 9, 2024 · After close | +0.6% |
| Q1 2024 | May 15, 2024 · After close | −0.6% |
| Q4 2023 | Mar 18, 2024 · After close | 0.0% |
| Q3 2023 | Nov 13, 2023 · After close | +1.0% |
| Q2 2023 | Aug 10, 2023 · After close | −0.9% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2023 | May 12, 2023 · Before open | +3.4% |
| Q4 2022 | Mar 30, 2023 · After close | +5.9% |
| Q3 2022 | Nov 10, 2022 · After close | −10.4% |
| Q2 2022 | Aug 15, 2022 · Before open | +1.1% |
| Q1 2022 | May 16, 2022 · Before open | −1.8% |
| Q4 2021 | Mar 25, 2022 · After close | −21.1% |
| Quarter to Sep 30, 2021 | Nov 15, 2021 · Before open | −0.7% |
| Quarter to Jun 30, 2021 | Aug 16, 2021 · After close | −3.7% |
| Quarter to Mar 31, 2021 | May 17, 2021 · Before open | +0.2% |
| Quarter to Dec 31, 2020 | Mar 31, 2021 · Before open | +5.6% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| IPO Roadshow (October 2023) | IPO roadshow | 27 slides | Oct 4, 2023 |
| Investor Presentation (August 2023) | Investor deck | 24 slides | August 2023 |
| Investor Presentation (June 2023) | Investor deck | 21 slides | June 2023 |
| Investor Presentation (March 2023) | Investor deck | 35 slides | March 2023 |
| Investor Presentation (January 2023) | Investor deck | 24 slides | January 2023 |
| Investor Presentation (November 2022) | Investor deck | 24 slides | November 2022 |
| IPO Roadshow (October 2022) | IPO roadshow | 30 slides | Oct 6, 2022 |
| Investor Presentation (May 2018) | Investor deck | 24 slides | May 25, 2018 |
| Investor Presentation (July 2017) | Investor deck | 20 slides | Jul 14, 2017 |
| Investor Presentation (May 2017) | Investor deck | 15 slides | May 2017 |
All 17 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (March 2017) | Investor deck | 16 slides | March 2017 |
| Investor Presentation (February 2017) | Investor deck | 16 slides | February 2017 |
| Investor Presentation (February 2017) | Investor deck | 16 slides | February 2017 |
| Investor Presentation (January 2017) | Investor deck | 16 slides | January 2017 |
| Investor Presentation (December 2016) | Investor deck | 15 slides | December 2016 |
| Investor Presentation (September 2016) | Investor deck | 14 slides | September 2016 |
| Investor Presentation (August 2016) | Investor deck | 12 slides | August 2016 |
IPO
Priced at US$6.00 a share on Jun 26, 2017.
- Price
- US$6.00 a share
- Shares offered
- 5,500,000 shares of common stock
- Offering size
- US$33 million
- Underwriters
- OPPENHEIMER & CO., NATIONAL SECURITIES CORPORATION · In the order on the cover
- Shares delivered
- On or about Jun 30, 2017
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Mar 28, 2017 |
| Filed publicly | Apr 28, 2017 |
| Amended 3 times | Newest Jun 23, 2017 |
| Shares registered with an exchange | Jun 14, 2017 |
| Declared effective by the SEC | Jun 26, 2017 |
| Final prospectus, with the price | Jun 28, 2017 |
Filings
| Filing | Filed |
|---|---|
| 424B2 · Prospectus | Jun 28, 2017 |
| EFFECT · Notice that a registration is effective | Jun 26, 2017 |
| S-1MEF · Registration of more shares for the same offering | Jun 26, 2017 |
| CERTNAS · Nasdaq's certificate of listing | Jun 26, 2017 |
| S-1/A · Registration statement, amended | Jun 23, 2017 |
| CORRESP · Letter to the SEC | Jun 23, 2017 |
| CORRESP · Letter to the SEC | Jun 23, 2017 |
| S-1/A · Registration statement, amended | Jun 23, 2017 |
| CORRESP · Letter to the SEC | Jun 21, 2017 |
| CORRESP · Letter to the SEC | Jun 21, 2017 |
All 19 filings
| Filing | Filed |
|---|---|
| 8-A12B · Registration of shares for listing on an exchange | Jun 14, 2017 |
| CORRESP · Letter to the SEC | Jun 13, 2017 |
| CORRESP · Letter to the SEC | Jun 13, 2017 |
| S-1/A · Registration statement, amended | May 22, 2017 |
| CORRESP · Letter to the SEC | Apr 28, 2017 |
| S-1 · Registration statement | Apr 28, 2017 |
| UPLOAD · Letter from the SEC | Apr 25, 2017 |
| UPLOAD · Letter from the SEC | Apr 5, 2017 |
| DRS · Draft registration statement | Mar 28, 2017 |
Open IPO · From the cover of the final prospectus (424B2) filed Jun 28, 2017
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.40M | 0 | ||||||||
| Research and development | 1.04M | 6.64M | 6.13M | 2.70M | 1.25M | 2.87M | 22.2M | 17.7M | 6.70M | 1.33M |
| Operating income | -3.08M | -11.3M | -14.5M | -8.04M | -3.74M | -5.21M | -26.3M | -21.8M | -11.4M | -2.38M |
| Interest expense | 0 | 294.0K | 420.0K | |||||||
| Income tax | 2.00K | 0 | 0 | 0 | ||||||
| Net income | -2.91M | -11.7M | -10.4M | -3.55M | -3.73M | -5.15M | -25.9M | -21.5M | -12.3M | -3.18M |
| Earnings per share, basic | -0.93 | -15.79 | -73.48 | -1.63 | -0.22 | -0.31 | -1.65 | -2.10 | -1.85 | -1.11 |
| Earnings per share, diluted | -0.22 | -0.31 | -1.65 | -2.10 | -1.85 | -1.11 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.85M | 2.59M | 1.78M | 6.71M | 3.76M | 3.13M | 8.74M | 2.67M | 11.8M | 197.0K |
| Short-term investments | 0 | 10.0M | 0 | |||||||
| Current assets | 3.96M | 3.25M | ||||||||
| Total assets | 2.93M | 2.67M | 1.85M | 6.84M | 3.96M | 3.25M | 8.91M | 4.53M | 22.2M | 197.0K |
| Accounts payable | 155.0K | 78.0K | 129.0K | 304.0K | 143.0K | 354.0K | 3.09M | 1.54M | 334.0K | |
| Current liabilities | 1.10M | 816.0K | 1.20M | 3.58M | 509.0K | 886.0K | 2.12M | 5.16M | 2.79M | 6.42M |
| Total liabilities | 1.10M | 816.0K | 1.20M | 3.58M | 509.0K | 886.0K | 2.12M | 5.16M | 2.79M | 8.45M |
| Shareholders' equity | 1.83M | 2.80M | 1.58M | 3.90M | 3.45M | 2.36M | 6.80M | -631.0K | 19.4M | -8.25M |
| Shares outstanding | 3.18M | 2.11M | 341.3K | 4.77M | 1.41M | 16.7M | 16.7M | 10.7M | 10.3M | 3.26M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -1.83M | -9.03M | -9.45M | -7.60M | -3.75M | -4.61M | -26.3M | -18.2M | -6.80M | -1.63M |
| Cash from investing | 0 | -3.00M | 0 | -1.00M | 0 | 10.0M | -10.0M | 0 | ||
| Cash from financing | 2.09M | 9.84M | 7.53M | 10.5M | 4.38M | 0 | 32.3M | -895.0K | 28.4M | 1.81M |
| Share buybacks | 0 | -1.10M | ||||||||
| Change in cash | 261.0K | 811.0K | -4.92M | 2.94M | 631.0K | -5.61M | 6.07M | -9.11M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Nov 6, 2026 | Quarterly report | SEC |
| 10-Q · Quarterly report | Aug 6, 2026 | Quarterly report | SEC |
| 10-Q · Quarterly report | May 8, 2026 | Quarterly report | SEC |
| 10-K · Annual report | Mar 30, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 23, 2026 | Material contract | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 17, 2026 | Big-stake notice | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Jan 6, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 8-K · Current report | Dec 31, 2025 | Meeting outcome | SEC |
| EFFECT · Notice that a registration is effective | Dec 17, 2025 | Other filings | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| POS AM · Amendment to an effective registration | Dec 15, 2025 | Offer document | SEC |
| RW · Request to withdraw a registration | Dec 15, 2025 | Other filings | SEC |
| DEF 14A · Proxy statement | Dec 5, 2025 | Meeting notice | SEC |
| 8-K · Current report | Nov 18, 2025 | Current report | SEC |
| 10-Q · Quarterly report | Nov 13, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 12, 2025 | Material contract | SEC |
| 10-Q · Quarterly report | Aug 14, 2025 | Quarterly report | SEC |
| 25-NSE | Jul 18, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | May 15, 2025 | Quarterly report | SEC |
| 8-K · Current report | Apr 30, 2025 | Acquisition or disposal | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Apr 2, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Apr 2, 2025 | Insider trade | SEC |
| 10-K · Annual report | Mar 31, 2025 | Annual report | SEC |
| 8-K · Current report | Mar 17, 2025 | Current report | SEC |
| 8-K · Current report | Mar 7, 2025 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Jan 3, 2025 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Jan 3, 2025 | Insider trade | SEC |
| S-3 · Registration statement | Dec 4, 2024 | Offer document | SEC |
| 4 · Change in ownership | Dec 3, 2024 | Insider trade | SEC |
| 8-K · Current report | Nov 29, 2024 | Current report | SEC |
| SC 13D/A · Big-stake notice, amended | Nov 15, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 14, 2024 | Quarterly report | SEC |
| 8-K · Current report | Nov 14, 2024 | Results | SEC |
| SC 13G · Big-stake notice | Nov 14, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 7, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2024 | Insider trade | SEC |
| 8-K · Current report | Sep 27, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Sep 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 25, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 9, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 9, 2024 | Results | SEC |
| S-8 · Registration statement for employee plans | Jul 12, 2024 | Offer document | SEC |
| 8-K · Current report | Jun 26, 2024 | Management or board change | SEC |
| 8-K · Current report | May 23, 2024 | Current report | SEC |
| 10-Q · Quarterly report | May 15, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 15, 2024 | Results | SEC |
| EFFECT · Notice that a registration is effective | May 13, 2024 | Other filings | SEC |
| 8-K · Current report | May 10, 2024 | Material contract | SEC |
| 424B3 · Prospectus | May 10, 2024 | Offer document | SEC |
| 424B5 · Prospectus | May 10, 2024 | Offer document | SEC |
| CORRESP · Letter to the SEC | May 8, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | May 8, 2024 | Other filings | SEC |
| S-3 · Registration statement | May 3, 2024 | Offer document | SEC |
| DEFA14A · Additional proxy material | May 3, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | May 3, 2024 | Meeting notice | SEC |
| SC 13G/A · Big-stake notice, amended | May 2, 2024 | Big-stake notice | SEC |
| 8-K · Current report | May 1, 2024 | Material contract | SEC |
| 8-K · Current report | Apr 26, 2024 | Current report | SEC |
| SC 13D/A · Big-stake notice, amended | Apr 17, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Apr 17, 2024 | Insider trade | SEC |
| 8-K · Current report | Mar 29, 2024 | Current report | SEC |
| DEF 14C | Mar 18, 2024 | Meeting notice | SEC |
| 10-K · Annual report | Mar 18, 2024 | Annual report | SEC |
| 8-K · Current report | Mar 18, 2024 | Results | SEC |
| 8-K · Current report | Mar 15, 2024 | Current report | SEC |
| PRE 14C | Mar 8, 2024 | Meeting notice | SEC |
| 8-K · Current report | Mar 8, 2024 | Meeting outcome | SEC |
| 8-K · Current report | Feb 23, 2024 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Feb 2, 2024 | Other filings | SEC |
| 424B3 · Prospectus | Feb 1, 2024 | Offer document | SEC |
| CORRESP · Letter to the SEC | Jan 30, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jan 29, 2024 | Other filings | SEC |
| DEF 14C | Jan 29, 2024 | Meeting notice | SEC |
| S-3 · Registration statement | Jan 24, 2024 | Offer document | SEC |
| PRE 14C | Jan 17, 2024 | Meeting notice | SEC |
| 8-K · Current report | Jan 12, 2024 | Meeting outcome | SEC |
| 8-K · Current report | Jan 8, 2024 | Material contract | SEC |
| 4 · Change in ownership | Jan 3, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Jan 2, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Dec 13, 2023 | Big-stake notice | SEC |
| 4 · Change in ownership | Dec 13, 2023 | Insider trade | SEC |
| SC 13G · Big-stake notice | Nov 28, 2023 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Nov 28, 2023 | Insider trade | SEC |
| 8-K · Current report | Nov 24, 2023 | Current report | SEC |
| 10-Q · Quarterly report | Nov 13, 2023 | Quarterly report | SEC |
| 8-K · Current report | Nov 13, 2023 | Results | SEC |
| 8-K · Current report | Nov 2, 2023 | Material contract | SEC |
| 424B4 · Prospectus | Nov 2, 2023 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Nov 1, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Oct 30, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Oct 30, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Oct 27, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Oct 27, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Oct 24, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Oct 24, 2023 | Other filings | SEC |
| S-1/A · Registration statement, amended | Oct 23, 2023 | Offer document | SEC |
| FWP · Free writing prospectus | Oct 5, 2023 | Offer document | SEC |
| FWP · Free writing prospectus | Oct 3, 2023 | Offer document | SEC |
| S-1/A · Registration statement, amended | Sep 29, 2023 | Offer document | SEC |
| 8-K · Current report | Sep 28, 2023 | Current report | SEC |
| 8-K · Current report | Sep 27, 2023 | Current report | SEC |
| UPLOAD · Letter from the SEC | Sep 21, 2023 | Other filings | SEC |
| S-1 · Registration statement | Sep 18, 2023 | Offer document | SEC |
| SC 13D/A · Big-stake notice, amended | Sep 18, 2023 | Big-stake notice | SEC |
| 4 · Change in ownership | Sep 12, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 12, 2023 | Insider trade | SEC |
| 8-K · Current report | Sep 8, 2023 | Material contract | SEC |
| 10-Q · Quarterly report | Aug 11, 2023 | Quarterly report | SEC |
| 8-K · Current report | Aug 10, 2023 | Results | SEC |
| 8-K · Current report | Jul 21, 2023 | Current report | SEC |
| 8-K · Current report | Jul 5, 2023 | Management or board change | SEC |
| 4 · Change in ownership | Jul 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 3, 2023 | Insider trade | SEC |
| 424B3 · Prospectus | Jun 28, 2023 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jun 28, 2023 | Other filings | SEC |
| 8-K · Current report | Jun 26, 2023 | Meeting outcome | SEC |
| CORRESP · Letter to the SEC | Jun 23, 2023 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jun 22, 2023 | Other filings | SEC |
| S-3 · Registration statement | Jun 16, 2023 | Offer document | SEC |
| 8-K · Current report | May 22, 2023 | Current report | SEC |
| 10-Q · Quarterly report | May 12, 2023 | Quarterly report | SEC |
| 8-K · Current report | May 12, 2023 | Results | SEC |
| 424B3 · Prospectus | May 4, 2023 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | May 4, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 1, 2023 | Other filings | SEC |
| DEFA14A · Additional proxy material | Apr 28, 2023 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 28, 2023 | Meeting notice | SEC |
| 8-K · Current report | Apr 17, 2023 | Current report | SEC |
| UPLOAD · Letter from the SEC | Apr 17, 2023 | Other filings | SEC |
| S-1 · Registration statement | Apr 10, 2023 | Offer document | SEC |
| 4 · Change in ownership | Apr 4, 2023 | Insider trade | SEC |
| 10-K · Annual report | Mar 31, 2023 | Annual report | SEC |
| 8-K · Current report | Mar 30, 2023 | Results | SEC |
| 8-K · Current report | Mar 8, 2023 | Management or board change | SEC |
| 8-K · Current report | Mar 2, 2023 | Material contract | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2023 | Big-stake notice | SEC |
| D | Feb 14, 2023 | Other filings | SEC |
| S-8 · Registration statement for employee plans | Feb 10, 2023 | Offer document | SEC |
| 8-K · Current report | Feb 10, 2023 | Current report | SEC |
| 8-K · Current report | Feb 3, 2023 | Management or board change | SEC |
| 8-K · Current report | Feb 1, 2023 | Material contract | SEC |
| 424B5 · Prospectus | Jan 31, 2023 | Offer document | SEC |
| 8-K · Current report | Jan 25, 2023 | Current report | SEC |
| DEFA14A · Additional proxy material | Jan 17, 2023 | Meeting notice | SEC |
| SC 13D/A · Big-stake notice, amended | Jan 6, 2023 | Big-stake notice | SEC |
| 4 · Change in ownership | Jan 4, 2023 | Insider trade | SEC |
| DEFA14A · Additional proxy material | Jan 4, 2023 | Meeting notice | SEC |
| SC 13G · Big-stake notice | Jan 4, 2023 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Dec 14, 2022 | Big-stake notice | SEC |
| DEFA14A · Additional proxy material | Nov 18, 2022 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Nov 18, 2022 | Meeting notice | SEC |
| 10-Q · Quarterly report | Nov 10, 2022 | Quarterly report | SEC |
| 8-K · Current report | Nov 10, 2022 | Results | SEC |
| PRE 14A · Preliminary proxy statement | Nov 8, 2022 | Meeting notice | SEC |
| 8-K · Current report | Nov 8, 2022 | Acquisition or disposal | SEC |
| 8-K · Current report | Nov 4, 2022 | Management or board change | SEC |
| SC 13D/A · Big-stake notice, amended | Oct 19, 2022 | Big-stake notice | SEC |
| 8-K · Current report | Oct 18, 2022 | Current report | SEC |
| SC 13G · Big-stake notice | Oct 17, 2022 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Oct 17, 2022 | Big-stake notice | SEC |
| 4 · Change in ownership | Oct 13, 2022 | Insider trade | SEC |
| 8-K · Current report | Oct 12, 2022 | Material contract | SEC |
| 424B4 · Prospectus | Oct 11, 2022 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Oct 7, 2022 | Other filings | SEC |
| FWP · Free writing prospectus | Oct 6, 2022 | Offer document | SEC |
| S-1/A · Registration statement, amended | Oct 6, 2022 | Offer document | SEC |
| CORRESP · Letter to the SEC | Oct 5, 2022 | Other filings | SEC |
| CORRESP · Letter to the SEC | Oct 5, 2022 | Other filings | SEC |
| S-1/A · Registration statement, amended | Oct 4, 2022 | Offer document | SEC |
| 8-K · Current report | Sep 30, 2022 | Current report | SEC |
| 8-K · Current report | Sep 22, 2022 | Current report | SEC |
| UPLOAD · Letter from the SEC | Sep 2, 2022 | Other filings | SEC |
| S-1 · Registration statement | Aug 31, 2022 | Offer document | SEC |
| 8-K · Current report | Aug 31, 2022 | Current report | SEC |
| DEF 14C | Aug 22, 2022 | Meeting notice | SEC |
| 10-Q · Quarterly report | Aug 15, 2022 | Quarterly report | SEC |
| 8-K · Current report | Aug 12, 2022 | Current report | SEC |
| PRE 14C | Aug 10, 2022 | Meeting notice | SEC |
| 3 · Initial statement of ownership | Aug 3, 2022 | Insider trade | SEC |
| 8-K · Current report | Aug 3, 2022 | Management or board change | SEC |
| 8-K · Current report | Jul 29, 2022 | Meeting outcome | SEC |
| SC 13D/A · Big-stake notice, amended | Jul 28, 2022 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | May 25, 2022 | Insider trade | SEC |
| 8-K · Current report | May 25, 2022 | Current report | SEC |
| 3 · Initial statement of ownership | May 17, 2022 | Insider trade | SEC |
| 8-K · Current report | May 16, 2022 | Material contract | SEC |
| 10-Q · Quarterly report | May 16, 2022 | Quarterly report | SEC |
| 8-K · Current report | May 13, 2022 | Management or board change | SEC |
This page holds 200 of 424 filings. Open Filings
Cap table
Built by 6ix from Avenue Therapeutics, Inc.’s releases · as of Aug 4, 2026
- Common shares
- 3,294,967
- Fully diluted
- 3,294,967
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 3,294,967 | Aug 4, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Aug 4, 2026 | 3,294,967 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Michael S. Weiss Other companies: Mustang Bio, Inc. (Chairman of the Board of Directors · Since at least Sep 26, 2016); Checkpoint Therapeutics Inc (Director · Since at least Sep 9, 2016); Fortress Biotech, Inc. (Executive Vice Chairman, Strategic Development · Since at least Jan 1, 2016); TG Therapeutics, Inc. (Chairman, President, and Chief Executive Officer · Since at least Dec 31, 2015); National Holdings Corporation (Director · Sep 12, 2016 – Sep 12, 2016 · Past) | Director · Mar 13, 2017 – Aug 7, 2018 · Past |
| Lindsay A. Rosenwald Other companies: Mustang Bio, Inc. (Director · Since at least Nov 5, 2026); Checkpoint Therapeutics Inc (Director · Since at least May 14, 2024); Journey Medical Corporation (Director · Since at least Mar 22, 2024); Fortress Biotech, Inc. (PRESIDENT, CEO & CHAIRMAN, Director · Since at least Nov 14, 2023) | Director · Since at least Sep 23, 2024 |
| Neil Herskowitz Other companies: Journey Medical Corporation (Director · Since at least Nov 16, 2021); Checkpoint Therapeutics Inc (Director · Since at least Jun 14, 2018); Mustang Bio, Inc. (Director · Since at least Jun 14, 2018); National Holdings Corporation (Director · Feb 12, 2018 – Feb 12, 2018 · Past) | Director · Since at least Oct 9, 2017 |
| David Jin Other companies: Mustang Bio, Inc. (Director · Since at least Nov 5, 2026); Fortress Biotech, Inc. (Chief Financial Officer and Head of Corporate Development · Since at least Apr 1, 2026) | Interim Chief Financial Officer and Chief Operating Officer · Since at least Nov 5, 2026 |
| Curtis Oltmans Other companies: Fulcrum Therapeutics, Inc. (Chief Legal Officer · Since at least Nov 30, 2020) | Director · Since at least Apr 1, 2021 |
| Elizabeth Garrett Ingram Other companies: MannKind Corporation (Chief Marketing Officer · Jun 14, 2018 – May 14, 2019 · Past) | Director · Aug 1, 2019 – Sep 12, 2019 · Past |
| Thomas Gregory Moore Other companies: Akorn Inc (Director · Jan 24, 2019 – Jan 24, 2019 · Past) | Director · Apr 30, 2019 – Apr 30, 2019 · Past |
| Akhtar Samad | Director · Mar 13, 2017 – Aug 7, 2018 · Past |
| Alexandra MacLean | Chief Executive Officer, Director · Since at least Feb 23, 2026 |
| Faith Charles | Director · Since at least Nov 5, 2026 |
All 14 people
| Person | Seat |
|---|---|
| Jaideep Ashok Gogtay | Director · Feb 8, 2019 – Feb 8, 2019 · Past |
| Jay Kranzler | Chairman of the Board of Directors · Since at least Nov 5, 2026 |
| Nishant Saxena | Director · Feb 8, 2019 – Feb 8, 2019 · Past |
| Scott Reines | Interim Chief Medical Officer · Mar 13, 2017 – Aug 7, 2018 · Past |
Log in to ask 6ix AI your own questions about Avenue Therapeutics, Inc.